Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Longitudinal Studies [NCBI]


Gene


Gene Link Information
Gain
01




OMIM


OMIM Link Information
gain
01
AD [NCBI] 0.00179964
RA [NCBI] 0.00177713
CFM1 [NCBI] 0.000732018
body mass index quantitative trait locus on chromosome 11 [NCBI] 0.000732018
body mass index quantitative trait locus on chromosome 6 [NCBI] 0.000732018
myasthenia, limb-girdle, with tubular aggregates [NCBI] 0.000732018
speech-sound disorder [NCBI] 0.00066762
stature quantitative trait locus 3 [NCBI] 0.00066762
stature as a quantitative trait [NCBI] 0.000581979
BMND3 [NCBI] 0.000550555
APOE [NCBI] 0.000503638
BULN1 [NCBI] 0.000479684
MDD [NCBI] 0.000468948
pygmy [NCBI] 0.000461132
twinning, dizygotic [NCBI] 0.00040179
SLE [NCBI] 0.000362023
apnea, obstructive sleep [NCBI] 0.000292403
diabetes mellitus, insulin-dependent, 2 [NCBI] 0.000287265
palatopharyngeal incompetence [NCBI] 0.000281043
kabuki syndrome [NCBI] 0.000258364
SHBG [NCBI] 0.000252583
PPR [NCBI] 0.000243309
KLK3 [NCBI] 0.000191759
PTH [NCBI] 0.000179499
HFM [NCBI] 0.000167287
APC [NCBI] 0.000155158
CRC [NCBI] 0.000122378
CF [NCBI] 0.000120235
pituitary dwarfism iii [NCBI] 0.000113715
aromatic l-amino acid decarboxylase deficiency [NCBI] 0.000112734
MAFD1 [NCBI] 0.000112584
VDR [NCBI] 0.000112088
LKS [NCBI] 0.000106715
OCP [NCBI] 9.02591e-05
DFNA28 [NCBI] 8.97212e-05
myasthenia, limb-girdle, autoimmune [NCBI] 8.97212e-05
HD [NCBI] 8.33403e-05
FTD [NCBI] 7.70067e-05
FA [NCBI] 7.18042e-05
SRS [NCBI] 6.38424e-05
PROP1 [NCBI] 5.36825e-05
FMF [NCBI] 5.2327e-05
cataract, age-related nuclear [NCBI] 5.19214e-05
RP [NCBI] 5.18195e-05
ETM1 [NCBI] 5.149e-05
CPI [NCBI] 4.60904e-05
ascaris lumbricoides infection, susceptibility to [NCBI] 4.53423e-05
TS [NCBI] 4.45823e-05
EGF [NCBI] 4.42202e-05
porencephaly, familial [NCBI] 4.05087e-05
BGLAP [NCBI] 3.97153e-05
GRHL2 [NCBI] 3.6906e-05
PMF [NCBI] 3.67033e-05
NGFB [NCBI] 3.47487e-05
MBL2 [NCBI] 3.39918e-05
body mass index [NCBI] 3.35772e-05
EGFR [NCBI] 3.28706e-05
RNASE3 [NCBI] 3.09405e-05
myoclonic epilepsy, neonatal, with suppression-burst pattern [NCBI] 3.09339e-05
MAOA [NCBI] 2.94033e-05
TG [NCBI] 2.80683e-05
sialuria [NCBI] 2.66496e-05
alzheimer disease, susceptibility to, mitochondrial [NCBI] 2.66496e-05
AMH [NCBI] 2.6491e-05
CUL5 [NCBI] 2.55694e-05
kawasaki disease [NCBI] 2.48714e-05
XYLT1 [NCBI] 2.35598e-05
MUC7 [NCBI] 2.35598e-05
GRB14 [NCBI] 2.20686e-05
GPD1 [NCBI] 2.20686e-05
CYP19A1 [NCBI] 2.14443e-05
ARPKD [NCBI] 2.10489e-05
MGP [NCBI] 2.08827e-05
CDAN1 [NCBI] 2.08827e-05
AGS1 [NCBI] 2.05194e-05
anemia, dyserythropoietic congenital, type i [NCBI] 2.05194e-05
CEACAM5 [NCBI] 1.99225e-05
COMP [NCBI] 1.94691e-05
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1 [NCBI] 1.93157e-05
aging [NCBI] 1.93157e-05
vitamin d-dependent rickets, type i [NCBI] 1.93157e-05
INHBB [NCBI] 1.90577e-05
EDNRA [NCBI] 1.83242e-05
MIRN16-1 [NCBI] 1.83242e-05
PWS [NCBI] 1.82504e-05
TNFRSF13C [NCBI] 1.76738e-05
lymphoma, non-hodgkin, familial [NCBI] 1.75217e-05
VRNI [NCBI] 1.74808e-05
crigler-najjar syndrome [NCBI] 1.71834e-05
alkaptonuria [NCBI] 1.71834e-05
HTR1B [NCBI] 1.70899e-05
CCL4 [NCBI] 1.70899e-05
NPPB [NCBI] 1.70899e-05
COMT [NCBI] 1.68812e-05
SOAT1 [NCBI] 1.65603e-05
ACE [NCBI] 1.59567e-05
HGD [NCBI] 1.56299e-05
pancreatic carcinoma [NCBI] 1.5348e-05
MBP [NCBI] 1.52885e-05
CCL3 [NCBI] 1.52166e-05
CCL18 [NCBI] 1.52166e-05
ESR1 [NCBI] 1.4637e-05
DA2A [NCBI] 1.45217e-05
KTCN1 [NCBI] 1.45217e-05
CYP1A2 [NCBI] 1.44717e-05
PCD [NCBI] 1.43287e-05
NCOA1 [NCBI] 1.38149e-05
IGFALS [NCBI] 1.38048e-05
hypertension, essential [NCBI] 1.37705e-05
TNFRSF11B [NCBI] 1.36835e-05
ADRB3 [NCBI] 1.35137e-05
IRDN [NCBI] 1.35137e-05
ALB [NCBI] 1.35112e-05
GAD2 [NCBI] 1.32281e-05
mannosidosis, alpha b, lysosomal [NCBI] 1.30225e-05
SLC6A4 [NCBI] 1.27629e-05
DRD [NCBI] 1.23402e-05
BIRC5 [NCBI] 1.22156e-05
osteogenesis imperfecta, type i [NCBI] 1.20291e-05
CRP [NCBI] 1.19896e-05
HLA-DRB1 [NCBI] 1.19896e-05
PD [NCBI] 1.17364e-05
LEP [NCBI] 1.16946e-05
CRYAB [NCBI] 1.15644e-05
FABP2 [NCBI] 1.11708e-05
thiourea tasting [NCBI] 1.10912e-05
glycogen storage disease ixa [NCBI] 1.06306e-05
ALMS [NCBI] 1.05183e-05
DYX1 [NCBI] 1.05183e-05
IL5 [NCBI] 1.02994e-05
AFP [NCBI] 1.00433e-05
CYP2A6 [NCBI] 9.98814e-06
ADRB2 [NCBI] 9.55429e-06
PRL [NCBI] 9.48871e-06
CAT [NCBI] 9.14726e-06
polycystic kidneys [NCBI] 9.14324e-06
apert syndrome [NCBI] 8.97574e-06
EPO [NCBI] 8.96955e-06
ADIPOQ [NCBI] 8.90534e-06
FMR1 [NCBI] 8.54279e-06
TCF7L2 [NCBI] 8.44137e-06
HP [NCBI] 8.33245e-06
phenylketonuria [NCBI] 8.25754e-06
GTS [NCBI] 8.11797e-06
AGT [NCBI] 7.81965e-06
PROCR [NCBI] 7.72351e-06
IGF1 [NCBI] 7.18498e-06
ASL [NCBI] 7.18498e-06
MMP9 [NCBI] 7.18498e-06
HCH [NCBI] 6.88055e-06
NF1 [NCBI] 6.79069e-06
GFAP [NCBI] 6.72281e-06
PCTT [NCBI] 6.51993e-06
DRD4 [NCBI] 6.26894e-06
MC4R [NCBI] 6.26894e-06
SMA3 [NCBI] 6.17615e-06
malaria, susceptibility to [NCBI] 6.17615e-06
MTTL1 [NCBI] 5.81197e-06
CCL22 [NCBI] 5.81197e-06
GLC1A [NCBI] 5.53547e-06
panencephalitis, subacute sclerosing [NCBI] 5.45171e-06
MPO [NCBI] 5.38818e-06
LPL [NCBI] 5.33242e-06
PCNA [NCBI] 5.33034e-06
HLA-A [NCBI] 5.18237e-06
SMN1 [NCBI] 5.0778e-06
MEN1 [NCBI] 4.97596e-06
GCK [NCBI] 4.97596e-06
POAG [NCBI] 4.95187e-06
BDNF [NCBI] 4.84545e-06
PJS [NCBI] 4.66774e-06
GH1 [NCBI] 4.63939e-06
DHFR [NCBI] 4.56441e-06
AVP [NCBI] 4.50413e-06
TPO [NCBI] 4.42888e-06
HSAN3 [NCBI] 4.41973e-06
VMD [NCBI] 4.17141e-06
leber optic atrophy [NCBI] 4.07413e-06
MS [NCBI] 3.73388e-06
ALGS1 [NCBI] 3.70757e-06
G6PD [NCBI] 3.6257e-06
MG [NCBI] 3.57684e-06
CHS [NCBI] 3.46535e-06
SLPI [NCBI] 3.37616e-06
CNTF [NCBI] 3.32485e-06
CFTR [NCBI] 3.30179e-06
RHO [NCBI] 3.16077e-06
PON1 [NCBI] 2.98765e-06
obesity [NCBI] 2.89805e-06
sickle cell anemia [NCBI] 2.89805e-06
CD [NCBI] 2.77579e-06
HHF2 [NCBI] 2.71791e-06
CASR [NCBI] 2.62023e-06
ABP1 [NCBI] 2.47677e-06
NPPA [NCBI] 2.41138e-06
ABCG2 [NCBI] 2.27558e-06
HEMB [NCBI] 2.10965e-06
HGF [NCBI] 2.07755e-06
PMD [NCBI] 2.06822e-06
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency [NCBI] 1.88124e-06
APOB [NCBI] 1.87279e-06
LQT1 [NCBI] 1.66932e-06
F3 [NCBI] 1.53828e-06
EIG [NCBI] 1.38624e-06
TLR2 [NCBI] 1.37327e-06
VEGF [NCBI] 1.23124e-06
NIDDM [NCBI] 1.21404e-06
LAM [NCBI] 1.20706e-06
AKR1B1 [NCBI] 1.09367e-06
SERPINA6 [NCBI] 9.82165e-07
FGFR3 [NCBI] 9.50441e-07
IAPP [NCBI] 8.50132e-07
TTR [NCBI] 6.44323e-07
AVSD [NCBI] 6.22198e-07
asthma, susceptibility to [NCBI] 6.22198e-07
ACHE [NCBI] 6.08995e-07
ACH [NCBI] 5.8958e-07
temporal arteritis [NCBI] 5.43589e-07
TH [NCBI] 4.58799e-07
XDH [NCBI] 4.57053e-07
alopecia, androgenetic [NCBI] 4.37456e-07
SLC6A3 [NCBI] 3.59503e-07
CRH [NCBI] 2.67264e-07
AHO [NCBI] 2.47153e-07
amyloidosis vi [NCBI] 2.05719e-07
CHAT [NCBI] 1.90632e-07
ADHD [NCBI] 1.45467e-07
GNRH1 [NCBI] 1.42641e-07
WBS [NCBI] 1.17719e-07
BLM [NCBI] 1.14742e-07
LS [NCBI] 1.14742e-07
HBB [NCBI] 9.9167e-08
SOD2 [NCBI] 8.88157e-08
hla-d histocompatibility type [NCBI] 7.61798e-08
MUC1 [NCBI] 6.44236e-08
krabbe disease [NCBI] 6.03834e-08
BWS [NCBI] 4.18672e-08
TLR4 [NCBI] 3.22646e-08
WHS [NCBI] 3.11407e-08
AR [NCBI] 3.04008e-08
TNF [NCBI] 1.08306e-08
PF4 [NCBI] 7.21495e-09
danubian endemic familial nephropathy [NCBI] 1.40465e-09
ADA [NCBI] 3.20422e-10




Database Center for Life Science